BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
171 results:

  • 1. METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
    Ao K; Yin M; Lyu X; Xiao Y; Chen X; Zhong S; Wen X; Yuan J; Ye M; Zhang J; Li X; Hao Y; Guo X
    Cancer Lett; 2024 Apr; 587():216658. PubMed ID: 38253218
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunohistopathological Study of Papillary Squamotransitional Carcinoma of Uterine Cervix.
    Dhande B; Khandeparkar SGS; Gogate BP; Joshi AR; Gosavi SS; Mishra PV
    Gulf J Oncolog; 2024 Jan; 1(44):16-24. PubMed ID: 38205568
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Is HPV-negative cervical carcinoma a different type of cervical cancer?
    Kulhan M; Bilgi A; Avci F; Ucar MG; Celik C; Kulhan NG
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9205-9212. PubMed ID: 37843334
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinicopathological analysis of primary gastric (gastrointestinal)-type mucoglandular lesion of endometrium].
    Zhang H; Xiang W; Ji ST; Xiao YP; Chen XC; Li J; Ning Y; Gu WY
    Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):586-591. PubMed ID: 37263923
    [No Abstract]    [Full Text] [Related]  

  • 5.
    Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
    J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A New Indicator to Differentiate Thyroid Follicular Inclusions in cervical Lymph Nodes from Patients with Thyroid cancer.
    Otsubo C; Mussazhanova Z; Kurohama H; Shalgimbayeva G; Ueki N; Matsuoka Y; Madiyeva M; Sato S; Yamashita H; Nakashima M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613940
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. It is more than uterine fibroids: Incidental discovery of adenoma malignum of the cervix.
    Abada E
    Malays J Pathol; 2022 Dec; 44(3):533-538. PubMed ID: 36591722
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma.
    Talia KL; Banet N; Buza N
    Pathology; 2023 Feb; 55(1):8-18. PubMed ID: 36503635
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for cancer Treatment in Japan.
    Naito Y; Sunami K; Kage H; Komine K; Amano T; Imai M; Koyama T; Ennishi D; Kanai M; Kenmotsu H; Maeda T; Morita S; Sakai D; Watanabe K; Shirota H; Kinoshita I; Yoshioka M; Mamesaya N; Ito M; Kohsaka S; Saigusa Y; Yamamoto K; Hirata M; Tsuchihara K; Yoshino T
    JAMA Netw Open; 2022 Dec; 5(12):e2245081. PubMed ID: 36469316
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals tp53 and CDKN2A Comutations : A Clinicopathologic Analysis With Re-evaluation of Diagnostic Criteria.
    Hopkins MR; Palsgrove DN; Ronnett BM; Vang R; Lin J; Murdock TA
    Am J Surg Pathol; 2022 Dec; 46(12):1611-1622. PubMed ID: 36069815
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Antibodies as biomarkers for cancer risk: a systematic review.
    Monroy-Iglesias MJ; Crescioli S; Beckmann K; Le N; Karagiannis SN; Van Hemelrijck M; Santaolalla A
    Clin Exp Immunol; 2022 Jul; 209(1):46-63. PubMed ID: 35380164
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
    Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prospects of Improving Early Ovarian cancer diagnosis Using cervical Cell Swabs.
    Biskup E; Wils RS; Hogdall C; Hogdall E
    Anticancer Res; 2022 Jan; 42(1):1-12. PubMed ID: 34969703
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
    Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
    [No Abstract]    [Full Text] [Related]  

  • 16. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
    Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Clear Cell Carcinoma of Cervix in a 12-Year-Old Girl: A Case Report].
    Liu J; Wang RY; Wei BB; Liu J; Hou MM; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):534-538. PubMed ID: 34018378
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
    Beilner D; Kuhn C; Kost BP; Vilsmaier T; Vattai A; Kaltofen T; Mahner S; Schmoeckel E; Dannecker C; Jückstock J; Mayr D; Jeschke U; Heidegger HH
    Arch Gynecol Obstet; 2021 Nov; 304(5):1307-1314. PubMed ID: 33861372
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Upregulation of
    Wang Q; Zheng W
    Biomed Res Int; 2021; 2021():6663367. PubMed ID: 33763482
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chemoradiation in locally advanced Ca Cx: Effect on NGAL levels.
    Dhankhar R; Chhabra S; Dahiya K; Ghalaut VS; Singh S; Gupta K
    J Cancer Res Ther; 2021; 17(1):198-203. PubMed ID: 33723155
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.